FindTrial
Sign In

Reirradiation of Recurrent Anaplastic Ependymoma Using Radiosurgery or Fractionated Stereotactic Radiotherapy

Reirradiation of Recurrent Anaplastic Ependymoma Using Radiosurgery or Fractionated Stereotactic Radiotherapy - Reirradiation of recurrent ependymoma using SRS or FSRT

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000017277
Enrollment
10
Registered
2015-04-25
Start date
2015-04-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Anaplastic Ependymoma

Interventions

None listed

Sponsors

Nagoya City University Graduate School of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Recurrent ependymoma patients were treated with stereotactic radiosurgery or fractionated stereotactic radiotherapy from 2007 to 2010. Patients who fulfilled the following inclusion criteria were treated and analyzed: 1) had previously undergone surgery and conventional radiotherapy as first-line treatment, 2) targets were located in or adjacent to the eloquent area of the brain, or were deep-seated, 3) the previously irradiated volume overlapped the target lesion.

Exclusion criteria

Exclusion criteria: Lesions previously treated with stereotactic radiosurgery or radiotherapy.

Design outcomes

Primary

MeasureTime frame
Local control rate—

Secondary

MeasureTime frame
Overall survival rate, progression free survival rate and toxicities—

Countries

Japan

Contacts

Public ContactTaro Murai

Nagoya City University Graduate School of Medical Sciences Department of Radiology

murai@syck.jp052-853-8274

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026